Institutional report - Arrhythmia Prevention of atrial fibrillation after coronary artery bypass grafting via atrial electromechanical interval and use of amiodarone prophylaxis

Interactive Cardiovascular and Thoracic Surgery

Volumn 8, Issue 4, 2009, Pages 421-425

  Roshanali, Farideh ^a   Mandegar, Mohammad Hossein ^a   Yousefnia, Mohammad Ali ^a   Alaeddini, Farshid ^a   Saidi, Bahare ^a  

^a Day General Hospital   (Iran)

Author keywords

Atrial fibrillation; Coronary artery disease

Indexed keywords

AMIODARONE; PLACEBO; ANTIARRHYTHMIC AGENT;

ADULT; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DISEASE DURATION; DOUBLE BLIND PROCEDURE; FEMALE; HEART ATRIUM FIBRILLATION; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; AGED; ARTICLE; DOPPLER ECHOCARDIOGRAPHY; DRUG ADMINISTRATION; DRUG EFFECT; ELECTROCARDIOGRAPHY; HEART ATRIUM FUNCTION; HEART RATE; LENGTH OF STAY; MIDDLE AGED; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; TIME; TREATMENT OUTCOME; CARDIOVASCULAR RISK; ECHOCARDIOGRAPHY; MEDICAL RESEARCH;

AGED; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; ATRIAL FUNCTION; CORONARY ARTERY BYPASS; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; ECHOCARDIOGRAPHY, DOPPLER; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; HEART RATE; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 65249185011     PISSN: 15699293     EISSN: None     Source Type: Journal    
DOI: 10.1510/icvts.2008.191403     Document Type: Conference Paper

References (15)

1. Daoud EG, Strickberger SA, Man KC, Goyal R, Deeb GM, Boiling SF, Pagani FD, Bitar C, Meissner MD, Morady F. Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery. N Engl J Med 1997; 337:1785-1791.
2. Crystal E, Connolly SJ, Sleik K, Ginger TJ, Yusuf S. Interventions on prevention of postoperative atrial fibrillation in patients undergoing heart surgery: a meta-analysis. Circulation 2002; 106:75-80.
3. Bagshaw SM, Galbraith PD, Mitchell LB, Sauve R, Exner DV, Ghali WA. Prophylactic amiodarone for prevention of atrial fibrillation after cardiac surgery: a meta-analysis. Ann Thorac Surg 2006;82:1927-1937.
4. Humphries JO. Unexpected instant death following successful coronary artery bypass graft surgery (and other clinical settings): atrial fibrillation, quinidine, procainamide, et cetera, and instant death. Clin Cardiol 21:711-718.
5. Perkerson KA, Gillespie EL, White CM, Kluger J, Takata H, Kardas M, Ismaili A, Coleman Cl. Impact of prophylactic amiodarone on length of hospital stay, stroke, and atrial fibrillation after cardiothoracic surgery. Pharmacotherapy 2005;25:320-324.
6. Mickleborough LL, Maruyama H, Mohamed S, Rappaport DC, Downar E, Butany J, Sun Z. Are patients receiving amiodarone at increased risk for cardiac operations? Ann Thorac Surg 1994;58:622-629.
7. Naccarelli GV, Rinkenberger RL, Dougherty AH, Giebel RA. Amiodarone: pharmacology and antiarrhythmic and adverse effects. Pharmacotherapy 1985;5:298-231.
8. Zebis LR, Christensen TD, Kristiansen IS, Hjortdal VE. Amiodarone cost effectiveness in preventing atrial fibrillation after coronary artery bypass graft surgery. Ann Thorac Surg 2008;85:28-32.
9. Barnes BJ, Kirkland EA, Howard PA, Grauer DW, Gorton ME, Kramer JB, Muehlebach GF, Reed WA. Risk-stratified evaluation of amiodarone to prevent atrial fibrillation after cardiac surgery. Ann Thorac Surg 2006;82:1332-1337.
10. Mathew JP, Fontes ML, Tudor IC, Ramsay J, Duke P, Mazer CD, Barash PG, Hsu PH, Mangano DT, Investigators of the Ischemia Research and Education Foundation, Multicenter Study of Perioperative Ischemia Research Group. A multicenter risk index for atrial fibrillation after cardiac surgery. J Am Med Assoc 2004;291:1720-1729.
11. Budeus M, Hennersdorf M, Rohlen S, Schnitzler S, Felix 0, Reimert K, Feindt P, Gams E, Wieneke H, Sack S, Erbel R, Perings C. Prediction of atrial fibrillation after coronary artery bypass grafting: the role of chemoreflex-sensitivity and P wave signal averaged ECG. Int J Cardiol 2006;106:67-74.
12. Tsang TS, Barnes ME, Bailey KR, Leibson CL, Montgomery SC, Takemoto Y, Diamond PM, Marra MA, Gersh BJ, Wiebers DO, Petty GW, Seward JB. Left atrial volume: important risk marker of incident atrial fibrillation in 1655 older men and women. Mayo Clin Proc 2001;76:467-475.
13. Hakala T, Hedman A. Predicting the risk of atrial fibrillation after coronary artery bypass surgery. Scand Cardiovasc J 2003; 37:309-315.
14. Roshanali F, Mandegar MH, Yousefnia MA, Rayatzadeh H, Alaeddini F, Amouzadeh F. Prediction of atrial fibrillation via atrial electromechanical interval after coronary artery bypass grafting. Circulation 2007; 116:2012-2017.
15. Hohnloser SH, Meinertz T, Dammbacher T, Steiert K, Jähnchen E, Zehender M, Fraedrich G, Just H. Electrocardiographic and antiarrhythmic effects of intravenous amiodarone: results of a prospective, placebo-controlled study. Am Heart J 1991;121(1 Pt 1):89-95.